Fibronectin and integrins in invasion and metastasis

Cancer and Metastasis Reviews

Volumn 14, Issue 3, 1995, Pages 173-189

  Akiyama, Steven K ^a   Olden, Kenneth ^b   Yamada, Kenneth M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

cell adhesion; fibronectin; integrins; invasion; metastasis

Indexed keywords

FIBRONECTIN; INTEGRIN; PEPTIDE;

AMINO ACID SEQUENCE; CANCER INVASION; CELL ADHESION; METASTASIS; PRIORITY JOURNAL; REVIEW;

AMINO ACID SEQUENCE; ANIMAL; CELL ADHESION; FIBRONECTINS; HUMAN; INTEGRINS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 0028808210     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/BF00690290     Document Type: Article

References (117)

1. Role of integrins and other cell adhesion molecules in tumor progression and metastasis
2. Cancer progression and growth: relationship of paracrine and autocrine growth mechansims to organ preference of metastasis
3. Tumor cell interactions with the extracellular matrix during invasion and metastasis
4. Tumor cell interactions with the vasculature: angiogenesis and tumor metastasis
5. Modulation of tumor cell response to chemotherapy by the organ environment
6. Alignment of biologically active domains in the fibronectin molecule
7. Domain structure of the carboxy-terminal half of human plasma fibronectin
8. Elution of fibronectin proteolytic fragments from a hydroxyapatite chromatography column
9. Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly
10. The interaction of fibronectin fragments with fibroblastic cells
11. Location of the cell attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule
12. Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function
13. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
14. Biologically active synthetic peptides as probes of embryonic development: a competitive peptide inhibitor of fibronectin function inhibits gastrulation in amphibian embryos and neural crest cell migration in avian embryos
15. Synthetic peptides that mimic the adhesive recognition signal of fibronectin: differential effects on cell-cell and cell-substratum adhesion in embryonic chick cells
16. Synthetic peptides competitively inhibit both direct binding to fibroblasts and functional biological assays for the purified cell-binding domain of fibronectin
17. Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable synergistic sites mediate adhesive function
18. Attachment, spreading and locomotion of avian neural crest cells are mediated by multiple adhesion sites on fibronectin molecules
19. Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis
20. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function
21. Function and receptor specificity of a minimal 20 kilodalton cell adhesive fragment of fibronectin
22. Human fibronectin: cell specific alternative mRNA splicing generates polypeptides chains differing in the number of internal repeats
23. Primary structure of human fibronectin: differential splicing may generate at least ten polypeptides from a single gene
24. Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion
25. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell-type specific adhesion
26. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively-spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine
27. Cell surface receptors for extracellular matrix proteins
28. Integrins and other cell adhesion molecules
29. VLA proteins in the integrin family: structures, functions, and their roles on leukocytes
30. Integrins
31. Inside-out integrin signaling
32. Integrins: versatility, modulation, and signaling in cell adhesion
33. Adhesion molecules in cancer: the role of integrins
34. Integrin-mediated adhesion and signaling in tumorigenesis
35. Integrins as dynamic regulators of vascular function
36. Electron microscopy and structural model of human fibronectin receptor
37. Cloning and sequence analysis of beta-4 cDNA: an integrin subunit that contains a unique 118 kd cytoplasmic domain
38. Amino acid sequence of a novel integrin β4 subunit and primary expression of the mRNA in epithelial cells
39. Epithelial integrin α4β6: complete primary structure of α6 and variants forms of β4
40. Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor
41. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits
42. The vitronectin receptor αvβ3 binds fibronectin and acts in concert with α5β1 in promoting cellular attachment and spreading on fibronectin
43. Lymphoid cells recognize an alternatively-spliced segment of fibronectin via the receptor α4β1
44. Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein
45. A novel integrin specificity exemplified by binding of the αvβ5 integrin to the basic domain of the HIV Tat protein and vitronectin
46. A study of the structure, function, and distribution of β5 integrins using novel anti-β5 monoclonal antibodies
47. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization
48. Possible involvement of the interaction of the α5 subunit of the α5β1 integrin with the synergistic region of the central cell-binding domain of fibronectin in cells to fibronectin binding
49. Identification of a novel integrin binding site in fibronectin: differential utilization by β3 integrins
50. Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin α4β1
51. Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by integrin α4β1
52. The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin α4β1
53. Activation of the α4β1 integrin through the β1 subunit induces recognition of the RGDS sequence in fibronectin
54. Cell surface proteins and malignant transformation
55. High molecular weight cell surfaceassociated glycoprotein (fibronectin) lost in malignant transformation
56. Fibronectins - adhesive glycoproteins of cell surface and blood
57. Regulation of fibronectin receptor distribution by transformation, exogenous fibronectin, and synthetic peptides
58. The Mr 140,000 fibronectin receptor complex in normal and virus-transformed human fibroblasts and in fibrosarcoma cells: identical localization and function
59. Differences in the biosynthesis and localization of the fibronectin receptor in normal and transformed cultured human cells
60. Changes in integrin receptors in oncogenically transformed cells
61. Enhanced fibronectin receptor expression in Rous sarcoma virus-induced tumors
62. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression
63. Integrin expression in human melanoma cells with differing invasive and metastatic potential
64. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
65. Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration
66. Inhibition of experimental metastasis of human breast carcinoma cells in athymic nude mice by anti-α5β1 fibronectin receptor integrin antobodies
67. Neural crest locomotion induced by antibodies to β1 integrins
68. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength
69. Basement membrane complexes with biological activity
70. Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor
71. Structure of a cDNA for the pro β2 chain of human type I collagen. Comparison with chick cDNA for pro α2(I) identifies structurally conserved features of the protein and the gene
72. Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains
73. Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides
74. Tumor invasion and the extracellular matrix
75. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells
76. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells
77. Anti-β1 integrin IgG inhibits pulmonary macrometastases and the size of micrometastases from a murine mammary carcinoma
78. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for α6 integrins
79. Isolation of α6β2 integrins from platelets and adherent cells by affinity chromatography on mouse laminin fragment E8 and human laminin pepsin fragment
80. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells
81. Expression of the integrin α4β1 on melanoma cells can inhibit the invasive stage of metastasis formation
82. Dynamic aspects of adhesion receptor function - integrins both twist and shout
83. Integrin cytoplasmic domains: mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signaling
84. Signaling by integrins: implications for tumorigenesis
85. Bioadhesion and cell behavior
86. Clues for understanding the structure and function of a prototype human integrin: the platelet glycoprotein IIb/IIIa complex
87. Signal transduction by integrins and its role in the regulation of tumor growth
88. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity
89. A novel transcriptional enhancer is involved in the prolactin- and extracellular matrix-dependent regulation of beta-casein gene expression
90. Insoluble fibronectin activates the Na/Hantiporter by clustering and immobilizing integrin alpha 5 beta 1, independent of cell shape
91. Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts
92. Calcium signaling capacity of the CD11b/CD18 integrin on human neutrophils
93. Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium
94. Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein
95. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins
96. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase
97. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly
98. Transmembrane signal transduction by integrin cytoplasmic domains expressed in single-subunit chimeras
99. Integrin-mediated cell adhesion activates mitogen-activated protein kinases
100. Matrix/integrin interaction activates the mitogen-activated protein kinase, p44erk-1 and p42erk-2
101. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase
102. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion
103. Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules
104. Molecular properties of poly(RGD) and its binding capacities to metastatic melanoma cells
105. Antimetastatic effects of synthetic peptides containing the core sequence of the type III connecting segment domain (IIICS) of fibronectin
106. Structural analysis of integrin recognition and the inhibition of integrin-mediated cell function by novel nonpeptidic surrogates of the Arg-Gly-Asp sequence
107. Novel Ψ-S-CH2 peptide-bond replacement and its utilization in the synthesis of nonpeptidic surrogates of the Leu-Asp-Val sequence that exhibit specific inhibitory activities on CD4+ T cell binding to fibronectin